Intellia Therapeutics, Inc. (NTLA) 8-K filings
- Ticker
- NTLA (Nasdaq)
- SEC CIK
- 1652130
- Industry (SIC)
- 2835 In Vitro & In Vivo Diagnostic Substances
- Incorporated in
- DE
- All filings
- SEC EDGAR
Recent 8-Ks
| Accepted (ET) | Form | Items | Filing |
|---|---|---|---|
| 2026-11-12 16:14 | 8-K | 2.02 Earnings release | Details |
| 2026-11-05 08:15 | 8-K | 2.02 Earnings release | Details |